ELOXATIN
Dead / Cancelled — Cancelled — Section 8 (as of 21 Feb 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76400845
- Registration number
- 2870847
- Mark type
- Word mark
- Filed
- 25 Apr 2002
- Published for opposition
- 18 May 2004
- Registered
- 10 Aug 2004
- Next maintenance due
- 10 Aug 2014
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, an anti-cancer preparation, excluding use for the treatment of prostate cancer, for parenteral administration
Owner
- SANOFI-AVENTIS U.S. LLC, BRIDGEWATER, NJ, US
- SANOFI-SYNTHELABO INC., NEW YORK, NY, US
- SANOFI-SYNTHELABO INC., NEW YORK, NY, US
- SANOFI-SYNTHELABO INC., NEW YORK, NY, US
- Sanofi-Synthelabo Inc., New York, NY, US
Prior registrations
Prosecution history
- 21 Feb 2025 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 10 Aug 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Aug 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Aug 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 23 Aug 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 22 Aug 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Aug 2014 — TEAS SECTION 8 & 9 RECEIVED
- 09 Nov 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Nov 2009 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Oct 2009 — TEAS SECTION 8 & 15 RECEIVED
- 29 Nov 2006 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP